MS Association Conference Empowers Patients

The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) is gearing up to host the MSMilan Patient Community Day, a significant event set for Saturday, October 14, 2023. The event will take place from 15:00 to 17:00, offering both in-person and online participation opportunities at Allianz MiCo – Milano Convention Centre in Italy. This day promises to provide a unique platform for individuals living with MS and related neurological conditions, including NeuroMyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody Associated Disorder (MOGAD), to gain insights and engage with top neurological experts.

Mar Tintorè, ECTRIMS President and Clinical Chief of Neurology at the Multiple Sclerosis Centre of Catalonia (Cemcat), says: “With over 2.8 million individuals around the world impacted by MS today, ECTRIMS wants to make sure it can share the latest research unveiled at our meetings with those most affected by it. We hope this event empowers those living with this and other related conditions to be better informed about decision-making affecting their treatment and care options.”

This inclusive event will be conducted in English, with live translation services available in Italian, German, French, Spanish, and Portuguese to ensure accessibility for a diverse audience.

Moreover, the MSMilan Patient Community Day will be highly interactive, aligning with ECTRIMS’ new #ECTRIMS4me campaign designed to give a voice to people living with MS. Participants are encouraged to submit questions, which will be addressed by MS experts during the event, fostering meaningful dialogue and knowledge-sharing.

Co-moderated by Mara Rocca, Associate Professor of Neurology at Vita-Salute University, and Prof. Mar Tintorè, this event recognizes the vital contributions of participants and their family members in the MS community.

This initiative aligns with ECTRIMS’ mission to advance research, treatment, and care in MS and related neurological conditions. The annual congress, a joint collaboration with ACTRIMS, expects to draw over 9,000 MS researchers, clinicians, and specialists, highlighting the significance of disseminating research knowledge to the broader MS community.

The MSMilan Patient Community Day is a collaborative effort between ECTRIMS, the American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), and the Italian Multiple Sclerosis Association (AISM). It marks the second edition of this event, following the successful pilot in Amsterdam, the Netherlands, last year. This event underscores the commitment of these organizations to empower individuals affected by MS and related conditions through knowledge sharing and community engagement.